Treatt Plc
OOTC:TTTRF3.50
USD
-0.50
(-12.50%)
ISIN
GB00BKS7YK08
Return %
Stock
S&P 500
1Y
7.36
14.20
3Y
-51.72
81.12
5Y
-77.93
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Manprit Singh Randhawa
- Full Time Employees
- 353
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Skyliner Way Bury St. Edmunds CS United Kingdom IP32 7FR
- IPO Date
- Jun 22, 1989
- Website
- treatt.com
- Similar Companies
- Business
- Treatt plc manufactures and supplies natural extracts and ingredients to the flavor, fragrance, beverage, and consumer goods industries worldwide. Founded in 1886 and headquartered in Bury St. Edmunds, United Kingdom, the company operates production and sales facilities in the UK, USA, China, and other regions, serving markets including carbonates, juices, energy drinks, RTD teas and coffees, kombucha, spirits, and low/no alcohol beverages. Its core products encompass citrus ingredients such as essential oils, blends, natural isolates, TreattZest, and TreattClear; tea solutions including Treattaromes, TrueTaste, and botanicals; coffee extracts; fruits and vegetables covering berries, tropical fruits, melons, and honeys; botanicals; herbs, spices, and florals; high-impact and aroma chemicals; health and wellness extracts; and sugar reduction technologies. Treatt generates the majority of its revenue from the USA, with additional contributions from the UK, Germany, Ireland, China, and the rest of Europe and Americas. In 2025, the company agreed to a recommended cash acquisition by Natara Global Ltd, controlled by Exponent Private Equity, at 290 pence per share valuing the business at approximately £156.6 million; the deal, approved by the board for its complementary product portfolios, enhanced geographic reach, and growth investment potential, awaits shareholder approval of at least 75% and regulatory clearances, with closure expected in 2025.